LAUREN ISDALE: Open Payments
NPI 1881298834 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 39 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $770 · 2025 $945
Food & beverage: $945
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $135 |
| ABBVIE INC. | 4 | $92 |
| Lundbeck LLC | 3 | $85 |
| Janssen Pharmaceuticals, Inc | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Neurocrine BioSciences, Inc. | 2 | $72 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| Bausch Health US, LLC | 4 | $68 |
| Tris Pharma Inc | 3 | $61 |
| Alkermes, Inc. | 2 | $56 |
Products named: CAPLYTA, REXULTI, VRAYLAR, SPRAVATO, INGREZZA, AUSTEDO XR, APLENZIN, Dyanavel XR.
Industry payments across IL — which companies pay providers there.
